Discover our

Services for Media

Are you a media representative looking for content on Bayer? This section provides news, press photos, TV Footage and more.

News

Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer
March 30, 2020
Not intended for U.S. and UK Media

Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer

Read more
Bayer to boost Germany’s COVID-19 analysis capacity by several thousand tests per day
March 30, 2020
Thanks to Bayer research apparatus and active involvement by the workforce:

Bayer to boost Germany’s COVID-19 analysis capacity by several thousand tests per day

Read more
Rivaroxaban significantly reduced risk of major venous thromboembolism following nonmajor orthopaedic surgery
March 29, 2020
Not intended for U.S. and UK Media - New study results add to solid evidence for the efficacy and safety of Rivaroxaban in the prevention of venous thromboembolism:

Rivaroxaban significantly reduced risk of major venous thromboembolism following nonmajor orthopaedic surgery

Read more
News Overview
Calendar

Tuesday, April 28, 2020

Annual Stockholder's Meeting 2020


Our Services

Publications

Get easy access to the different reports, magazines and brochures from Bayer.

Newsletter

We will keep you informed about the latest news

Our Media Streams

Social Media Overview